BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19209893)

  • 1. Structure-activity relationships of antitubercular nitroimidazoles. 2. Determinants of aerobic activity and quantitative structure-activity relationships.
    Kim P; Kang S; Boshoff HI; Jiricek J; Collins M; Singh R; Manjunatha UH; Niyomrattanakit P; Zhang L; Goodwin M; Dick T; Keller TH; Dowd CS; Barry CE
    J Med Chem; 2009 Mar; 52(5):1329-44. PubMed ID: 19209893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships of antitubercular nitroimidazoles. 1. Structural features associated with aerobic and anaerobic activities of 4- and 5-nitroimidazoles.
    Kim P; Zhang L; Manjunatha UH; Singh R; Patel S; Jiricek J; Keller TH; Boshoff HI; Barry CE; Dowd CS
    J Med Chem; 2009 Mar; 52(5):1317-28. PubMed ID: 19209889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, reduction potentials, and antitubercular activity of ring A/B analogues of the bioreductive drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824).
    Thompson AM; Blaser A; Anderson RF; Shinde SS; Franzblau SG; Ma Z; Denny WA; Palmer BD
    J Med Chem; 2009 Feb; 52(3):637-45. PubMed ID: 19099398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antitubercular activity of 7-(R)- and 7-(S)-methyl-2-nitro-6-(S)-(4-(trifluoromethoxy)benzyloxy)-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazines, analogues of PA-824.
    Li X; Manjunatha UH; Goodwin MB; Knox JE; Lipinski CA; Keller TH; Barry CE; Dowd CS
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2256-62. PubMed ID: 18358721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and structure-activity relationships of aza- and diazabiphenyl analogues of the antitubercular drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824).
    Kmentova I; Sutherland HS; Palmer BD; Blaser A; Franzblau SG; Wan B; Wang Y; Ma Z; Denny WA; Thompson AM
    J Med Chem; 2010 Dec; 53(23):8421-39. PubMed ID: 21069962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and structure-activity relationships of varied ether linker analogues of the antitubercular drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5h-imidazo[2,1-b][1,3]oxazine (PA-824).
    Thompson AM; Sutherland HS; Palmer BD; Kmentova I; Blaser A; Franzblau SG; Wan B; Wang Y; Ma Z; Denny WA
    J Med Chem; 2011 Oct; 54(19):6563-85. PubMed ID: 21846109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-activity studies of biphenyl analogues of the tuberculosis drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824).
    Palmer BD; Thompson AM; Sutherland HS; Blaser A; Kmentova I; Franzblau SG; Wan B; Wang Y; Ma Z; Denny WA
    J Med Chem; 2010 Jan; 53(1):282-94. PubMed ID: 19928920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, structure and biological evaluation of novel bicyclic nitroimidazole derivatives.
    Zaprutko L; Zwawiak J; Augustynowicz-Kopeć E; Zwolska Z; Bartoszak-Adamska E; Nowicki W
    Arch Pharm (Weinheim); 2012 Jun; 345(6):463-7. PubMed ID: 22266946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships of antitubercular nitroimidazoles. 3. Exploration of the linker and lipophilic tail of ((s)-2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-yl)-(4-trifluoromethoxybenzyl)amine (6-amino PA-824).
    Cherian J; Choi I; Nayyar A; Manjunatha UH; Mukherjee T; Lee YS; Boshoff HI; Singh R; Ha YH; Goodwin M; Lakshminarayana SB; Niyomrattanakit P; Jiricek J; Ravindran S; Dick T; Keller TH; Dartois V; Barry CE
    J Med Chem; 2011 Aug; 54(16):5639-59. PubMed ID: 21755942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of sugar-derived chiral nitroimidazoles as potential antimycobacterial agents.
    Mugunthan G; Sriram D; Yogeeswari P; Ravindranathan Kartha KP
    Carbohydr Res; 2011 Sep; 346(13):1760-6. PubMed ID: 21714959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships for amide-, carbamate-, and urea-linked analogues of the tuberculosis drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824).
    Blaser A; Palmer BD; Sutherland HS; Kmentova I; Franzblau SG; Wan B; Wang Y; Ma Z; Thompson AM; Denny WA
    J Med Chem; 2012 Jan; 55(1):312-26. PubMed ID: 22148391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antitubercular activity of monocyclic nitroimidazoles: insights from econazole.
    Lee SH; Kim S; Yun MH; Lee YS; Cho SN; Oh T; Kim P
    Bioorg Med Chem Lett; 2011 Mar; 21(5):1515-8. PubMed ID: 21277200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virtual generation of agents against Mycobacterium tuberculosis. A QSAR study.
    Besalú E; Ponec R; de Julián-Ortiz JV
    Mol Divers; 2003; 6(2):107-20. PubMed ID: 14761161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-activity relationships for extended side chain analogues of the antitubercular drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824).
    Palmer BD; Sutherland HS; Blaser A; Kmentova I; Franzblau SG; Wan B; Wang Y; Ma Z; Denny WA; Thompson AM
    J Med Chem; 2015 Apr; 58(7):3036-59. PubMed ID: 25781074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alkylated/aminated nitroimidazoles and nitroimidazole-7-chloroquinoline conjugates: Synthesis and anti-mycobacterial evaluation.
    Shalini ; Viljoen A; Kremer L; Kumar V
    Bioorg Med Chem Lett; 2018 May; 28(8):1309-1312. PubMed ID: 29551480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity relationships of antitubercular 2-nitroimidazooxazines bearing heterocyclic side chains.
    Sutherland HS; Blaser A; Kmentova I; Franzblau SG; Wan B; Wang Y; Ma Z; Palmer BD; Denny WA; Thompson AM
    J Med Chem; 2010 Jan; 53(2):855-66. PubMed ID: 19968290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacophore modeling and density functional theory analysis for a series of nitroimidazole compounds with antitubercular activity.
    Tawari NR; Degani MS
    Chem Biol Drug Des; 2011 Sep; 78(3):408-17. PubMed ID: 21689377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A QSAR study of biphenyl analogues of 2-nitroimidazo-[2, 1-b] [1, 3]-oxazines as antitubercular agents using genetic function approximation.
    Ray S; Roy PP
    Med Chem; 2012 Jul; 8(4):717-26. PubMed ID: 22530914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of 5-substitution on the electrochemical behavior and antitubercular activity of PA-824.
    Bollo S; Núñez-Vergara LJ; Kang S; Zhang L; Boshoff HI; Barry CE; Squella JA; Dowd CS
    Bioorg Med Chem Lett; 2011 Jan; 21(2):812-7. PubMed ID: 21168331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and anti-tubercular activity of 2-nitroimidazooxazines with modification at the C-7 position as PA-824 analogs.
    Kang YG; Park CY; Shin H; Singh R; Arora G; Yu CM; Lee IY
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3650-3. PubMed ID: 26199118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.